Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-25

Study Completion Date

2025-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this interventional study is to evaluate the risk of atrial fibrillation (AF) and other cardiac arrhythmias and diseases in breast cancer patients treated with radiation therapy (RT).

In addition to regular follow-up of patients by the radiation oncologist for 5 years, cardiovascular screening at the end of follow-up, combining the use of a connected watch and a cardiological check-up, could make it possible to identify precisely the types and frequencies of these sometimes asymptomatic, and probably underestimated, cardiac diseases.

The main questions it aims to answer are:

* To assess the incidence of AF and other cardiac arrhythmias and diseases occurring within 5 years after RT
* To evaluate absorbed doses in the heart and cardiac substructures (chambers, conduction nodes, coronaries, pulmonary veins) based on auto-segmentation models developped with deep learning algorithms
* To investigate whether the risk of AF and other cardiac arrhythmias and diseases is associated with cardiac irradiation characterized by these absorbed doses (dose-response relationship)

Participants will be included between 2023 and 2025, 5 years after their RT:

* Retrospective data collection will be based on a medical questionnaire designed to identify cardiac pathologies present prior to RT and those having occured in the past, between RT and 5 years post-RT.
* Cross-sectional data collection will be based on screening for cardiac pathologies using a connected watch worn for 1 month (silent AF screening) and a cardiology consultation (including ECG and echocardiography) to identify cardiac pathologies at 5 years post-RT possibly not identified in the retrospective data collection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Atrial Fibrillation Health Literacy and Information Technology Trial

NCT04075994

Atrial Fibrillation Familial Atrial Fibrillation Arrythmia, Cardiac +2 more

COMPLETED NA

Atrial Fibrillation in Active Cancer Patients

NCT04696081

Cancer Drug Toxicity Atrial Fibrillation +1 more

RECRUITING

Connected Cardiology to Control Cardiac Rythm

NCT06091514

Atrial Fibrillation

NOT_YET_RECRUITING NA

Cardiac Monitoring of Post-Operative Cancer Patients Experiencing Atrial Fibrillation

NCT01253590

Post-Operative Cancer Patients Experiencing Atrial Fibrillation

TERMINATED

Radiotherapy-Associated Atrial Fibrillation

NCT05927246

Atrial Fibrillation New Onset

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Radiation Toxicity Atrial Fibrillation Cardiac Arrhythmia Cardiac Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast cancer patients treated with RT 5 years ago

Retrospective and cross-sectional data collection based on a medical questionnaire and screening for atrial fibrillation and other cardiac arrhythmias and diseases.

Screening for atrial fibrillation and other cardiac arrhythmias and diseases

Intervention Type DIAGNOSTIC_TEST

In addition to retrospective data collection based on a medical questionnaire, a 5-year post-RT cardiovascular screening will include:

* connected smartwatches for atrial fibrillation screening
* complete ECG for other cardiac arrhythmias
* echocardiography for other cardiac diseases (including cardiac dysfunction, cardiomyopathy, valvulopathy, ...)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Screening for atrial fibrillation and other cardiac arrhythmias and diseases

In addition to retrospective data collection based on a medical questionnaire, a 5-year post-RT cardiovascular screening will include:

* connected smartwatches for atrial fibrillation screening
* complete ECG for other cardiac arrhythmias
* echocardiography for other cardiac diseases (including cardiac dysfunction, cardiomyopathy, valvulopathy, ...)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women treated surgically for primary cancer of the left or right breast and for whom adjuvant treatment is RT with irradiation of the breast or chest wall and possibly irradiation of lymph node chains,
* Adjuvant radiotherapy performed at Clinique Pasteur between 2018 and 2020,
* 5-year post-RT follow-up radiation oncologist consultation performed at Clinique Pasteur
* Age ≥ 65 years at the time of the 5-year post-RT follow-up consultation
* Own a smartphone and able to understand and use digital tools alone and/or with the help of a caregiver ;
* Patient having consented to connected follow-up,
* Be affiliated to a social security scheme or equivalent
* Be willing to participate in the study and have signed the consent form

Exclusion Criteria

* History of cancer before breast cancer RT
* Recurrence of breast cancer or other cancer treated after breast cancer RT
* History of atrial fibrillation prior to breast cancer RT

Minimum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No